FDA OKs Elacestrant for ESR1+ Advanced, Metastatic Breast Cancer

Österreich Nachrichten Nachrichten

FDA OKs Elacestrant for ESR1+ Advanced, Metastatic Breast Cancer
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 Medscape
  • ⏱ Reading Time:
  • 56 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 55%

FDA approves novel drug for advanced or metastatic breastcancer

, experts raised concerns about the adequacy of the"standard of care" control arm in EMERALD, particularly that single agents were used at a time when combination therapy is becoming more common.

"The expression 'standard of care' is applied generously, as the control arm is restricted" to single agents and no combinations, which"may have led to a substandard" comparison group, Timothée Olivier, MD, Geneva University Hospital, Switzerland, and Vinay Prasad, MD, MPH, University of California San Francisco, said in an editorial quoted in the piece.

EMERALD investigators acknowledged that there were issues with the control group, noting that in the"United States and Europe, combination therapy with fulvestrant" — instead of single agents —"is increasingly being used as the second-line [standard of care] treatment." However, the goal of the study"was to compare a novel endocrine therapy vs currently available endocrine therapies," not combination regimens, the investigators said.

Also,"the benefit of elacestrant over fulvestrant and AIs in our monotherapy trial…suggests that incorporating elacestrant as the preferred endocrine therapy backbone in future earlier-line combination studies is a promising strategy.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Medscape /  🏆 386. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Michigan Senate OKs earlier presidential primary, to dismay of GOPMichigan Senate OKs earlier presidential primary, to dismay of GOP'This bill uplifts the voice and vote of Michigan Democrats and Michigan Republicans, and gives every Michigander an early, deserving chance to choose the next president of the United States,' said state Sen. Jeremy Moss, the lead sponsor of the bill.
Weiterlesen »

Utah governor OKs bill banning gender-affirming health careUtah governor OKs bill banning gender-affirming health careUtah’s Republican governor on Saturday signed bills that ban youth from receiving gender-affirming health care and allow families to receive scholarships to pay for education outside the public school system, both measures that are part of larger nationwide movements.
Weiterlesen »

FDA proposes allowing gay and bisexual monogamous men to donate bloodFDA proposes allowing gay and bisexual monogamous men to donate bloodFDA announces it will ease blood donation restrictions on gay and bisexual men, including allowing those in monogamous relationships to donate.
Weiterlesen »

FDA Will Now Allow Blood Donations From Gay, Bisexual Men and Transgender WomenFDA Will Now Allow Blood Donations From Gay, Bisexual Men and Transgender WomenThe FDA has announced that it will be ending blood donation restrictions that have discriminated against gay and bisexual men since 1985.
Weiterlesen »

FDA okays first human stool therapy - Nature BiotechnologyFDA okays first human stool therapy - Nature BiotechnologyIn Brief: US_FDA approves a first-in-class live microbiota-based therapy to prevent recurrent Clostridium difficile infections
Weiterlesen »



Render Time: 2025-03-13 11:01:56